← Leaderboards
Beau Richard Webber
University Of Minnesota
$2,853,539
Attributed
$3,776,428
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,776,428 · 6
By mechanism
R37$1,644,656 · 1
R21$1,242,994 · 3
R61$734,778 · 1
R03$154,000 · 1
Top collaborators
- Branden S Moriarity3 shared
- Logan G Spector2 shared
- R Scott Mcivor1 shared
- Jonathan N Sachs1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Jakub Tolar$8,610,650
- Branden S Moriarity$9,306,595
- Kacey Linnea Guenther Bui$128,503
- Mark J Osborn$748,457
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsPublic Health RelevanceIn VitroIn VivoGenesGenome EngineeringCrispr/Cas TechnologyPhenotypeEngineeringStem CellsGenomeCell TypeSiteInduced Pluripotent Stem CellExhibitsGenomicsTechnologyMolecularMediatingMouse ModelChromatinGenetic EngineeringKnock-OutVector
Grant awards (11)
Human iPSC-Derived Chimeric Antigen Receptor Macrophages to Modulate Inflammation and Combat Tau-Induced Pathology$734,778
R61 · FY2025 · AG
Deconvoluting the Ewing sarcoma genetic program using ancestry-informed human iPSC modeling$425,698
R37 · FY2025 · CA · contact PI
In vivo and ex vivo gene editing for Artemis-deficient SCID$420,771
R21 · FY2025 · AI
Deconvoluting the Ewing sarcoma genetic program using ancestry-informed human iPSC modeling$593,852
R37 · FY2024 · CA · contact PI
Deconvoluting the Ewing sarcoma genetic program using ancestry-informed human iPSC modeling$625,106
R37 · FY2023 · CA · contact PI
Multiplex Engineered Human Lymphocytes for Therapeutic Protein Delivery$232,500
R21 · FY2022 · AI · contact PI
Determining the cell of origin in Ewing sarcoma through genomic analysis$215,985
R21 · FY2021 · CA
Multiplex Engineered Human Lymphocytes for Therapeutic Protein Delivery$193,750
R21 · FY2021 · AI · contact PI
Determining the cell of origin in Ewing sarcoma through genomic analysis$179,988
R21 · FY2020 · CA
Engineered Systems for Conditional and Temporal Gene Manipulation in Primary Lymphohematopoietic Cells$77,000
R03 · FY2020 · AI
Engineered Systems for Conditional and Temporal Gene Manipulation in Primary Lymphohematopoietic Cells$77,000
R03 · FY2019 · AI